Watson's Opana ANDA Triggers Endo, Penwest Suit
Watson Pharmaceuticals Inc. has revealed that it is facing a patent infringement suit from Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. following the generics maker's bid for approval of its own...To view the full article, register now.
Already a subscriber? Click here to view full article